The Latest Breaking News from Vaccine

Exclusive: Less than 40 per cent of frontline staff were vaccinated ahead of winter, risking staff shortages and flu transmission

The World Health Organisation (WHO) has added the second malaria vaccine to its list of prequalified vaccines. The vaccine, R21/ Matrix-M malaria vaccine, was recommended by the WHO for malaria treatment in October 2023. The R21 vaccine is the second malaria vaccine prequalified by the WHO, following the RTS, S/AS01…

Infectious disease experts say the best way to protect yourself from the JN.1 subvariant is to get the updated Covid 19 vaccine

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

As the 1906 UK general election results rolled in, it became clear that the Conservative party, after 11 years in power, had suffered one of the most disastrous defeats in its history. Of 402 Conservative MPs, 251 lost their seats, including their candidate for prime minister, defeated on a 22.5%…

MRNA, a type of genetic material that provides the instructions your cells need in order to make proteins, used to be a term mainly used by scientists. But since COVID arrived many of us are now familiar with it thanks to the mRNA-based vaccines.

Because it is so easy to change the mRNA recipes, cancer vaccines can be part of a personalized medicine plan where doctors sample a patient’s tumour, sequence key genes and adjust the mRNA treatment to include recipes specific to that patient’s cancer. Clinical trials using this personalized approach for pancreatic…

Low vaccination rates against influenza, COVID-19 and RSV, along with an increase in respiratory diseases, could pose a potential strain on the healthcare system, the CDC warned.

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.